Factors supporting optimisation of psychotropic deprescribing in people with intellectual disabilities within the UK: a modified Delphi study
Overprescribing psychotropic medication for people with intellectual disabilities increases the risk of adverse effects and has prompted deprescribing initiatives internationally. However, factors that support optimal psychotropic deprescribing in this population remain unclear. The aim of this stud...
Saved in:
| Main Authors: | Danielle Adams, Richard P. Hastings, Ian Maidment, Peter E. Langdon |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Psychiatry |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2025.1652988/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
General polypharmacy, psychotropic polypharmacy, attitudes of patients on psychotropic deprescribing, and associated factors in adult psychiatric outpatients: a survey study in a comprehensive specialized hospital, northwest Ethiopia
by: Muluken Adela Alemu, et al.
Published: (2025-04-01) -
The US Deprescribing Research Network: a network to catalyze deprescribing science
by: Raha Shahroodi, et al.
Published: (2025-07-01) -
Deprescribing within English care homes: guidance and recommendations from the STOPPING project
by: Krystal Warmoth, et al.
Published: (2025-12-01) -
Deprescribing anticholinergics to preserve brain health: reducing the risk of dementia through deprescribing (R2D2): study protocol for a randomized clinical trial
by: Noll L. Campbell, et al.
Published: (2024-11-01) -
Tapering (deprescribing) of benzodiazepine tranquilizers
by: D. A. Sychev, et al.
Published: (2019-03-01)